Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Chondroplasty Market In The Coming Years?
The market for chondroplasty has seen significant expansion in the recent past. It is projected to escalate from $13.77 billion in 2024 to $14.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historic period include a rise in sports-related injuries, patient inclination towards non-total joint replacement, advancements in postoperative care, improvement in healthcare provider capabilities, and a growing incidence of joint disorders.
In the coming years, the chondroplasty market is anticipated to experience robust growth, reaching $18.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. The ascension anticipated in the forecast period can be credited to factors such as the merger of regenerative medicine, emphasis on outpatient procedures, the emergence of new biomaterials, an increase in musculoskeletal diseases, and the growth of the elderly population. The forecast period will also see significant trend shifts with the adoption of technology in rehabilitation, arthroscopic practices, cartilage repair and regeneration, the invention of cutting-edge surgical equipment, and the assimilation of navigation systems.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp
Which Growth Drivers Are Shaping The Chondroplasty Market Outlook?
The escalating prevalence of joint-related conditions is anticipated to drive the expansion of the chondroplasty market. These disorders are conditions that harm a joint’s health and functionality, often arising from joint overutilization or unexpected injuries, such as accidents or injuries during sports. Chondroplasty addresses these joint-related conditions by mending the impaired joint cartilage. For example, as per The Lancet’s data, a UK-based organization that disseminates books and periodic data, the number of gout cases, a type of inflammatory arthritis that impacts the joints, escalated from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Thus, the escalating prevalence of joint-related conditions is propelling the expansion of the chondroplasty market.
What Is The Segment Breakdown Of The Chondroplasty Market?
The chondroplastymarket covered in this report is segmented –
1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
Subsegments:
1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation; Low-Frequency Ablation
2) By Abrasion Chondroplasty: Mechanical Abrasion; Arthroscopic Abrasion
3) By Patellar Chondroplasty: Open Patellar Chondroplasty; Arthroscopic Patellar Chondroplasty
4) By Meniscal Repair: Suturing Techniques; Meniscal Allograft Transplantation
5) By Tissue Removal: Arthroscopic Debridement; Open Debridement
6) By Other Types: Microfracture Techniques; Osteochondral Autograft Transplantation
What New Opportunities Are Emerging From Trends In The Chondroplasty Market?
Leading firms in the chondroplasty market are progressing with the development of autologous chondrocytes to improve cartilage repair. This method employs the patient’s own cells, which lowers the risk of immune rejection and encourages natural healing. Autologous chondrocytes are cartilage cells sourced from the patient’s body, often extracted from a non-load-bearing area of the joint. An example of this is Vericel Corporation, a US-based biopharmaceutical company, which gained FDA approval and commenced commercial availability of MACI Arthro (Matrix Autologous Chondrocyte Implantation) in August 2024. This comprises a significant breakthrough in treating cartilage defects in the knee. MACI Arthro enables orthopedic surgeons to execute the procedure through small incisions with custom-made instruments, offering a less invasive alternative to conventional methods. The expectation is that this will speed up patient recovery and lessen post-surgery complications.
Who Are The Major Stakeholders Operating In The Chondroplasty Market?
Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Chondroplasty Market?
North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13185&type=smp
Browse Through More Reports Similar to the Global Chondroplasty Market 2025, By The Business Research Company
Orthopedic Power Tools Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/orthopedic-power-tools-global-market-report
Orthopedic Regenerative Surgical Products Global Market Report 2025
Orthopedic Soft Tissue Repair Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/orthopedic-soft-tissue-repair-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model